Martin Stengelin, PhD, is a Senior Scientific Manager at Meso Scale Diagnostics, LLC (MSD®). He has 17 years of immunoassay development experience. Dr. Stengelin began his career at Dade Behring (now Siemens), and has been at MSD since 2003. He earned his Ph.D. at the Max Planck Institute for Biophysics in Frankfurt and his MBA at the University of Delaware. Dr. Stengelin is currently the Principal Investigator of a 5-year NIH grant to develop sample sparing assays for monitoring immune responses. He also manages assay development projects related to infectious diseases, immunology, and cancer.